| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 10/19/2006 | US20060235041 New isothiazoloquinolones and related compounds as anti-infective agents |
| 10/19/2006 | US20060235034 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 10/19/2006 | US20060234983 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 10/19/2006 | US20060234314 Selective binding and analysis of macromolecules |
| 10/19/2006 | CA2604686A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors |
| 10/19/2006 | CA2604115A1 Spiro-oxindole compounds and their uses as therapeutic agents |
| 10/18/2006 | EP1712554A1 Pyridobenzoxazine derivative |
| 10/18/2006 | EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 10/18/2006 | CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 10/18/2006 | CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds |
| 10/18/2006 | CN1280292C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 10/18/2006 | CN1279916C 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
| 10/17/2006 | US7122662 Tricyclic compound having spiro union |
| 10/17/2006 | US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 10/17/2006 | US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 10/17/2006 | US7122525 Targeted therapeutics and uses thereof |
| 10/17/2006 | US7122081 Reducing particle size of organic pigments by milling the crude pigment in the presence of a water soluble styrene copolymer dispersant, optionally a defoamer, optionally an additive, and greater than about 10 wt. % water, and isolating the organic pigment |
| 10/17/2006 | CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 10/12/2006 | WO2006106804A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/12/2006 | WO2006105945A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 10/12/2006 | US20060229329 Such as 2-anilino-4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)pyrimidine; antiproliferative agents; rheumatoid arthritis |
| 10/12/2006 | US20060229314 5-oxo-7-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-4,5-dihydro-thieno[3,2-b]pyridine-6-carbonitrile; angiogenesis antagonist; antitumor, antiinflammatoy agent; indirect inhibition of cytokines, growth factors, chemokines, and lymphokines |
| 10/12/2006 | US20060229306 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 10/12/2006 | US20060229302 Tricyclic indole derivatives and their use in the treatment of alzheimer's disease |
| 10/12/2006 | US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses |
| 10/12/2006 | US20060228557 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 10/12/2006 | US20060228325 that bind target proteins, such as monoclonal antibodies, for in vitro bioassays, or for in vivo diagnosis or therapy |
| 10/12/2006 | DE102005016170A1 4,5,6,7- Tetrahydro-isoxazolo(4,5c)pyridin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln 4,5,6,7-tetrahydro-isoxazolo (4,5c) pyridine compounds and their use for the preparation of medicaments |
| 10/12/2006 | CA2603493A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments |
| 10/12/2006 | CA2602025A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/11/2006 | EP1709974A2 Method of treating cardiovascular disease using rapamycin |
| 10/11/2006 | EP1709053A1 Stable salts of olanzapine |
| 10/11/2006 | EP1709044A2 Oxazolidinone-quinolone hybrid antibiotics |
| 10/11/2006 | EP1709015A1 Organic compounds |
| 10/11/2006 | CN1845928A Method for the manufacture of thip |
| 10/11/2006 | CN1845926A Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1845905A PPAR-activating compound and pharmaceutical composition comprising the compound |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/10/2006 | US7119205 Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| 10/10/2006 | US7119196 Anxiolytic agents with reduced sedative and ataxic effects |
| 10/10/2006 | US7119180 Halogenation with a diphenylhalosulfonimide, deblocking the protected hydroxyl group; optional esterification or addition salt formation |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119088 A bi-heterocycle-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives; for therapy of dysmenorrhoea, anxiety disorder, asthma, atherosclerosis, cardiac failure, cardiovascular disease, cataract, central nervous system disease, motion sickness, Raynaud's disease, rheumatoid arthritis; chemical synthesis |
| 10/10/2006 | CA2481848C Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation |
| 10/05/2006 | WO2006104897A2 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | WO2006104226A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006103399A1 Hiv integrase inhibitors |
| 10/05/2006 | US20060223845 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| 10/05/2006 | US20060223844 Mitotic kinesin inhibitors |
| 10/05/2006 | US20060223809 Thieno [2,3,-d]pyridazin-4(5H)-ones; modulation of autoimmune diseases with T-cell antiproliferatives; antiinflammatory; organ transplant rejection; AIDS; chronic obstructive pulmonary disease (COPD); asthma |
| 10/05/2006 | US20060223798 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 10/05/2006 | US20060223794 Novel olanzapine forms and related methods of treatment |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | CA2602574A1 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | CA2585333A1 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 10/04/2006 | EP1706413A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 10/04/2006 | EP1706409A1 Compounds useful in therapy |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1451194B1 Preparation of levofloxacin hemihydrate |
| 10/04/2006 | CN1842580A Photochromic compounds |
| 10/03/2006 | US7115744 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 10/03/2006 | US7115741 Anticoagulants and antiagglomerants |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115736 Process for preparing imidazopyran derivatives |
| 10/03/2006 | US7115622 Amido ether substituted imidazoquinolines |
| 10/03/2006 | US7115612 Arylsulfonamides as antiviral agents |
| 10/03/2006 | US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS |
| 10/03/2006 | US7115545 5-Phenylcarbonyloxy-1-methyl-1H-pyrazol-4-yl)-(8-methyl-sulfonyl-3a,4-dihydro-3H-indeno[1,2-c]isoxazol-5-yl)methanone |
| 10/03/2006 | CA2249654C Benzoxazines for enhancing synaptic response |
| 10/03/2006 | CA2151507C Pharmaceutical composition containing bicyclic type compounds |
| 09/28/2006 | WO2006101603A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | US20060217563 tetraheterocyclicspiro compound containing pyrazole ring; for treating a variety of autoimmune and inflammatory diseases |
| 09/28/2006 | US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/28/2006 | US20060217411 2-Phenyl- pyrazoloquinolin-3-ones and pyrazolo(thio)chromen-3-ones, e.g., N-[4-(6-Fluoro-3-oxo-3,5-dihydropyrazolo[4,3-c]quinolin-2-yl)-phenyl]-2-methyl-butyramide; used to treat rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis |
| 09/28/2006 | US20060217409 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | CA2602140A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/27/2006 | CN1839134A [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112674 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 09/26/2006 | US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/21/2006 | WO2006081182A3 Antibacterial agents |
| 09/21/2006 | WO2006078711A3 Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp |
| 09/21/2006 | US20060211695 Fused heterocyclic kinase inhibitors |
| 09/21/2006 | US20060211657 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701962A2 Rifamycin analogs and uses thereof |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1549624A4 Inhibitors of fatty acid amide hydrolase |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | CN1835955A 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 09/20/2006 | CN1835954A 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |